Overexpression of proteasome 26S subunit non-ATPase 6 protein and its clinicopathological significance in intrahepatic cholangiocarcinoma

doi:10.4254/wjh.v16.i11.1282

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

HTML

Figures (1-4)

Sum=2

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=5

Nov 27, 2024 (publication date) through Nov 6, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Nov 27, 2024; 16(11): 1282-1289
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1282

Full Size Figure Download Figure

Figure 3 Expression of proteasome 26S subunit non-ATPase 6 protein in adjacent non-tumor tissue of intrahepatic cholangiocarcinoma and intrahepatic cholangiocarcinoma tissue. A: Images are derived from adjacent non-tumor tissue samples of intrahepatic cholangiocarcinoma, representing the tissue at 50 μm magnification; B: Images are derived from intrahepatic cholangiocarcinoma samples, representing the tissue at 50 μm magnification.

Citation: Tang ZQ, Tang YL, Qin K, Li Q, Chen G, Huang YB, Li JJ. Overexpression of proteasome 26S subunit non-ATPase 6 protein and its clinicopathological significance in intrahepatic cholangiocarcinoma. World J Hepatol 2024; 16(11): 1282-1289
URL: https://www.wjgnet.com/1948-5182/full/v16/i11/1282.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i11.1282